Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for c…
This bill amends the Social Security Act to ban the use of quality-adjusted life years (QALYs) and similar measures in coverage, payment, reimbursement, and incentive determinations across Federal health care programs including Medicare (Parts A/B, Advantage, and Part D), Medicaid (including managed care), CHIP, and the Federal Employees Health Benefits program. It prevents Federal agencies or States from waiving that prohibition through demonstration or waiver authorities.
Whether banning QALYs is primarily a protection against discrimination (liberal and conservative framing) or an elimination of a necessary cost-effectiveness tool used to manage limited public dollars (centrist and some liberals).
Relative to its intended legislative type, this bill functionally implements a clear statutory prohibition on use of QALYs and similar measures across Federal health programs and adds an annual GAO reporting requirement and Prevention Fund adjustments.
This bill amends the Social Security Act to ban the use of quality-adjusted life years (QALYs) and similar measures in coverage, payment, reimbursement, and incentive determinations across Federal health care programs including Medicare (Parts A/B, Advantage, and Part D), Medicaid (including managed care), CHIP, and the Federal Employees Health Benefits program.
It prevents Federal agencies or States from waiving that prohibition through demonstration or waiver authorities.
The bill also increases mandated annual transfers to the Prevention and Public Health Fund for fiscal years 2026–2031 and requires the Comptroller General to report annually on how QALYs negatively impact people with intellectual and developmental disabilities.
As a narrowly focused but broadly applied statutory prohibition, the bill addresses a sensitive policy instrument and limits agency/state flexibility—features that can attract strong, organized opposition. It includes a modest spending increase for the Prevention Fund that could complicate consensus. While the subject can draw sympathetic support from disability advocates and some members across the aisle, the absence of compromise features and the cross-cutting impacts on major programs make enactment into law unlikely without substantial modification or major legislative tradeoffs.
Relative to its intended legislative type, this bill functionally implements a clear statutory prohibition on use of QALYs and similar measures across Federal health programs and adds an annual GAO reporting requirement and Prevention Fund adjustments. The bill is explicit about where the prohibition applies and prevents waiver, but it provides limited definitional detail, limited enforcement or administrative implementation instructions, and minimal anticipatory treatment of edge cases.
Whether banning QALYs is primarily a protection against discrimination (liberal and conservative framing) or an elimination of a necessary cost-effectiveness tool used to manage limited public dollars (centrist and some liberals).
These are examples from the analysis, not a ranked list of the most-affected groups.
Whether banning QALYs is primarily a protection against discrimination (liberal and conservative framing) or an elimination of a necessary cost-effectiveness tool used to manage limited public dollars (centrist and some…
A mainstream liberal would view the bill as a partial win and a partial concern.
They would welcome protections for people with disabilities and the increase in prevention and public health funding, but worry that an across-the-board ban on QALYs removes an analytic tool used to measure cost-effectiveness and allocate limited public dollars efficiently.
They would be particularly concerned about losing methods for comparing value across treatments when negotiating drug prices or designing benefit packages, and would seek alternatives that protect disabled people while preserving evidence-based, equitable evaluation methods.
A pragmatic centrist would note the bill's intent to prevent discrimination against disabled and elderly people in coverage decisions and appreciate the boost to public health funding, but would have significant fiscal and operational concerns.
They would be wary of removing analytic tools that help allocate constrained resources and would ask for clearer definitions, cost estimates, and transition guidance before backing it.
They would likely push for amendments to retain rigorous, non-discriminatory evaluation methods and for an assessment of budgetary impacts before implementation.
A mainstream conservative would generally view the bill favorably as a measure that prevents government 'rationing' of care and protects vulnerable populations from being devalued by cost-per-QALY calculations.
They would welcome the statutory prohibition on QALYs across federal programs and the explicit ban on waivers that could enable use of such measures.
However, some fiscal conservatives might be concerned about mandated increases to the Prevention and Public Health Fund and any resulting spending increases.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
As a narrowly focused but broadly applied statutory prohibition, the bill addresses a sensitive policy instrument and limits agency/state flexibility—features that can attract strong, organized opposition. It includes a modest spending increase for the Prevention Fund that could complicate consensus. While the subject can draw sympathetic support from disability advocates and some members across the aisle, the absence of compromise features and the cross-cutting impacts on major programs make enactment into law unlikely without substantial modification or major legislative tradeoffs.
The bill has not accumulated any surfaced votes yet.
Whether banning QALYs is primarily a protection against discrimination (liberal and conservative framing) or an elimination of a necessary…
As a narrowly focused but broadly applied statutory prohibition, the bill addresses a sensitive policy instrument and limits agency/state f…
Relative to its intended legislative type, this bill functionally implements a clear statutory prohibition on use of QALYs and similar measures across Federal health programs and adds an annual GAO reporting requirement…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.